Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Environmentally friendly inhaler decision-making with personalized care in asthma and chronic obstructive pulmonary disease: a qualitative study.

Exploratory research in clinical and social pharmacy·2025

Same author

Cardiovascular risk management in patients using antipsychotics: a qualitative feasibility study.

BJGP open·2025

Same author

Educational needs of people with COPD or asthma entering pulmonary rehabilitation and their significant others: A cross-sectional study.

Chronic respiratory disease·2025

Same author

Transmural collaborative care model for cardiovascular risk management and medication review in patients using antipsychotics in primary care (TACTIC): A study protocol of an incomplete stepped wedge cluster randomized trial.

Contemporary clinical trials communications·2025

Same author

The Significance of a Cerebrovascular Accident Outcome Prediction Model for Patients, Family Members, and Health Care Professionals: Qualitative Evaluation Study.

JMIR human factors·2025

Same author

Author Correction: Transmural collaborative care model for the review of antipsychotics: a feasibility study of a complex intervention.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: Mar 20, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Effectiveness of a medication-adherence tool: study protocol for a randomized controlled trial.

Mirrian Hilbink¹, Joyca Lacroix², Linda Bremer-van der Heiden²

¹Radboud University Medical Center, Radboud Institute for Health Sciences, IQ healthcare, PO box 9101, Code: 114 IQ healthcare, 6500 HB, Nijmegen, The Netherlands.

|June 4, 2016

Summary

This study tested a new tool to help patients with chronic conditions adhere to their medications. The tool identifies nonadherence risks and barriers, aiming to improve medication adherence for better disease control.

Keywords:

Barriers Cardiovascular diseases Diabetes Medication adherence Primary care

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Mar 20, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Clinical Pharmacy
Health Services Research
Patient Adherence

Background:

Medication nonadherence affects over half of patients with chronic conditions, negatively impacting disease management and increasing healthcare costs.
Identifying nonadherence risks and barriers is crucial for developing effective interventions.
A novel tool was developed to assess nonadherence risks and barriers, offering tailored intervention strategies.

Purpose of the Study:

To evaluate the effectiveness of a new adherence tool in improving medication adherence among patients initiating cardiovascular or oral blood glucose-lowering medications.
To assess the tool's ability to identify and address barriers to medication adherence.

Main Methods:

A cluster-randomized controlled trial involving 25 pharmacies in the Netherlands.
Participants starting new cardiovascular or oral blood glucose-lowering medications completed an assessment of nonadherence risks and barriers.
The intervention group received a tailored intervention based on a graphic barrier profile, while the control group received usual care.

Main Results:

The primary outcome is medication adherence at 8 months for patients at high risk of nonadherence.
Secondary outcomes include differences in nonadherence risk between groups, predictive values of the baseline questionnaire, and adherence at 1 year.
Implementation facilitators and barriers of the adherence tool will also be assessed.

Conclusions:

This study protocol outlines a rigorous trial to determine the effectiveness of a novel adherence tool.
Findings are expected to provide valuable insights into improving medication adherence for chronic disease management.
The study aims to reduce the burden of nonadherence on patients and healthcare systems.